Sjögren's Syndrome News
- ACR 2022 Remibrutinib Safe for Sjögren's in Phase 2
- CARRA 2022 Lupus Mutation May Unlock Targeted Drugs for Patient Subset
- EULAR 2022 EULAR Congress Opens New Avenues for Learning, Collaborating
- EULAR CVD Management Guidance Focuses on Gout, Lupus, Vasculitis
- ACR 2021 Vitamin D and Omega-3 Supplements Reduce Autoimmune Disease Risk
- Small Fiber Neuropathy Rising in the US, But Why Is a Mystery
- NIAMS Director Reflects on Mentors, Spotlights Research Projects
- No Higher Risk for Rheumatic Flares Seen After COVID Vaccination
- Olympic Athletes Vulnerable to Everyday Health Risks
- COVID-19 Vaccination in RMD Patients: Safety Data 'Reassuring'
- ACR 2020 Sjögren’s Symptom Clusters May Identify Treatment Options
- ACR 2019 The Trick of Treating Cancer in Autoimmune Diseases
- Findings That Led to $183 Million Drug Development Deal Questioned
- Early-Onset Sjögren's Linked to More Severe Disease
- Another AE Identified With Checkpoint Inhibitors
- Cancer, Autoimmune Disorders Linked to Postsurgery GBS
- New Guidance on Managing Sjogren's Rheumatologic Problems
- Pediatric Cancer Survivors at High Risk for Autoimmune Disease
- New Name, Diagnostic Criteria for Neuromyelitis Optica
- Sjogren's: Hydroxychloroquine No Better Than Placebo